Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Glitnir banki hf. acquires Fischer Partners Fondkommision
Mandate

Glitnir banki hf. acquires Fischer Partners Fondkommision

July 21, 2006

Glitnir banki hf., previously Íslandsbanki hf., buys Fischer Partners for approximately SEK 425 million. The purchase-sum of approximately SEK 425 million, which was paid at the completion of the transaction, is made up of SEK 380 million for Fischer's share-capital and SEK 45 million for repayment of debts to Invik.

Vinge was the advisor for Glitnir banki hf. Vinge representatives included Michael Wigge, David Aversten, Mattias Hållberg and Dan Hanqvist.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026